6.7(top 5%)
impact factor
1.1K(top 20%)
papers
41.0K(top 10%)
citations
98(top 5%)
h-index
7.1(top 5%)
impact factor
1.4K
all documents
44.9K
doc citations
140(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Pulmonary aspergillosis: a clinical reviewEuropean Respiratory Review2011533
2Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review2012421
3Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseasesEuropean Respiratory Review2018370
4Epidemiology of COPDEuropean Respiratory Review2009362
5Comorbidities of COPDEuropean Respiratory Review2013353
6Antifibrotic activities of pirfenidone in animal modelsEuropean Respiratory Review2011350
7Protecting healthcare workers from SARS-CoV-2 infection: practical indicationsEuropean Respiratory Review2020313
8The pathophysiology of chronic thromboembolic pulmonary hypertensionEuropean Respiratory Review2017307
9Depression and anxiety in patients with COPDEuropean Respiratory Review2014286
10Tuberculosis and lung damage: from epidemiology to pathophysiologyEuropean Respiratory Review2018279
11Acute high-altitude sicknessEuropean Respiratory Review2017273
12Impact of exacerbations on COPDEuropean Respiratory Review2010244
13Cellular interactions in the pathogenesis of interstitial lung diseasesEuropean Respiratory Review2015231
14Scleroderma lung diseaseEuropean Respiratory Review2013230
15Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertensionEuropean Respiratory Review2017229
16Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthmaEuropean Respiratory Review2010225
17Malignant pleural mesothelioma: an update on investigation, diagnosis and treatmentEuropean Respiratory Review2016225
18Adult-onset asthma: is it really different?European Respiratory Review2013221
19Rheumatoid arthritis-associated lung diseaseEuropean Respiratory Review2015220
20Dysfunctional breathing: a review of the literature and proposal for classificationEuropean Respiratory Review2016217
21Pulmonary alveolar proteinosisEuropean Respiratory Review2011212
22Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 yearsEuropean Respiratory Review2012211
23The role of the right ventricle in pulmonary arterial hypertensionEuropean Respiratory Review2011210
24Pulmonary manifestations of Sjögren's syndromeEuropean Respiratory Review2016206
25Practical recommendations for exercise training in patients with COPDEuropean Respiratory Review2013200
26Spontaneous pneumothorax: epidemiology, pathophysiology and causeEuropean Respiratory Review2010193
27Fibrosing interstitial lung diseases: knowns and unknownsEuropean Respiratory Review2019191
28REVEAL: a contemporary US pulmonary arterial hypertension registryEuropean Respiratory Review2012190
29Exacerbations of COPDEuropean Respiratory Review2018189
30Cardiovascular disease and COPD: dangerous liaisons?European Respiratory Review2018187
31The right ventricle in pulmonary arterial hypertensionEuropean Respiratory Review2014185
32Climate change and respiratory diseasesEuropean Respiratory Review2014183
33Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertensionEuropean Respiratory Review2017183
34Night-time symptoms: a forgotten dimension of COPDEuropean Respiratory Review2011182
35Interstitial lung diseaseEuropean Respiratory Review2014182
36Malignant pleural effusion: from bench to bedsideEuropean Respiratory Review2016179
37Obesity hypoventilation syndromeEuropean Respiratory Review2019176
38The arterial load in pulmonary hypertensionEuropean Respiratory Review2010173
39Pathogenesis of pulmonary arterial hypertension: lessons from cancerEuropean Respiratory Review2013172
40The role of small airways in obstructive airway diseasesEuropean Respiratory Review2011170
41ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseasesEuropean Respiratory Review2019167
42Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotypeEuropean Respiratory Review2014166
43Matrix abnormalities in pulmonary fibrosisEuropean Respiratory Review2018165
44Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosisEuropean Respiratory Review2017162
45Cancer-associated thrombosis: the when, how and whyEuropean Respiratory Review2019160
46Physiology of the lung in idiopathic pulmonary fibrosisEuropean Respiratory Review2018159
47Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UKEuropean Respiratory Review2009157
48The therapy of idiopathic pulmonary fibrosis: what is next?European Respiratory Review2019157
49An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and JapanEuropean Respiratory Review2017156
50The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studiesEuropean Respiratory Review2021150